If the cancer worsens during treatment, your doctor will discuss next steps, including switching therapies
The initial report of those data will not disappear
The most probable scenario is that compounding pharmacies would be permitted to produce certain peptides under FDA oversight, allowing licensed health-care professionals to prescribe them. This would be similar to what happened with semaglutide, the active ingredient in GLP-1 medications like Ozempic, he says
Every month of continued operation is a month of accumulated legal risk
Nausea not common, but more likely at higher doses (500 mcg+) or if you inject on a full stomach
Unlike hormones or anabolic agents, BPC-157 is non-hormonal, non-steroidal, and does not disrupt natural endocrine function